The global PD-1 and PD-L1 Inhibitors market size was valued at USD 40690 million in 2022 and is forecast to a readjusted size of USD 140220 million by 2029 with a CAGR of 19.3% during review period.
PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.
North America is the largest consumption place, with a consumption market share nearly 60.40% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 20.66%. Market competition is intense. Merck, Bristol-Myers Squibb, Roche, AstraZeneca, Ono Pharmaceutical etc. are the leaders of the industry.
This report is a detailed and comprehensive analysis for global PD-1 and PD-L1 Inhibitors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global PD-1 and PD-L1 Inhibitors market size and forecasts, in consumption value ($ Million), sales quantity (L), and average selling prices (USD/ml), 2018-2029
Global PD-1 and PD-L1 Inhibitors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (L), and average selling prices (USD/ml), 2018-2029
Global PD-1 and PD-L1 Inhibitors market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (L), and average selling prices (USD/ml), 2018-2029
Global PD-1 and PD-L1 Inhibitors market shares of main players, shipments in revenue ($ Million), sales quantity (L), and ASP (USD/ml), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PD-1 and PD-L1 Inhibitors
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global PD-1 and PD-L1 Inhibitors market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Merck
Bristol-Myers Squibb
Roche
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
Merck KGaA
PD-1 Inhibitors
PD-L1 Inhibitors
Solid Tumors
Blood-related Tumors
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe PD-1 and PD-L1 Inhibitors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PD-1 and PD-L1 Inhibitors, with price, sales, revenue and global market share of PD-1 and PD-L1 Inhibitors from 2018 to 2023.
Chapter 3, the PD-1 and PD-L1 Inhibitors competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PD-1 and PD-L1 Inhibitors breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and PD-1 and PD-L1 Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of PD-1 and PD-L1 Inhibitors.
Chapter 14 and 15, to describe PD-1 and PD-L1 Inhibitors sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of PD-1 and PD-L1 Inhibitors
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global PD-1 and PD-L1 Inhibitors Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 PD-1 Inhibitors
1.3.3 PD-L1 Inhibitors
1.4 Market Analysis by Application
1.4.1 Overview: Global PD-1 and PD-L1 Inhibitors Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Solid Tumors
1.4.3 Blood-related Tumors
1.5 Global PD-1 and PD-L1 Inhibitors Market Size & Forecast
1.5.1 Global PD-1 and PD-L1 Inhibitors Consumption Value (2018 & 2022 & 2029)
1.5.2 Global PD-1 and PD-L1 Inhibitors Sales Quantity (2018-2029)
1.5.3 Global PD-1 and PD-L1 Inhibitors Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck PD-1 and PD-L1 Inhibitors Product and Services
2.1.4 Merck PD-1 and PD-L1 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business
2.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product and Services
2.2.4 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bristol-Myers Squibb Recent Developments/Updates
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche PD-1 and PD-L1 Inhibitors Product and Services
2.3.4 Roche PD-1 and PD-L1 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Roche Recent Developments/Updates
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca PD-1 and PD-L1 Inhibitors Product and Services
2.4.4 AstraZeneca PD-1 and PD-L1 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AstraZeneca Recent Developments/Updates
2.5 Ono Pharmaceutical
2.5.1 Ono Pharmaceutical Details
2.5.2 Ono Pharmaceutical Major Business
2.5.3 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product and Services
2.5.4 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Ono Pharmaceutical Recent Developments/Updates
2.6 Regeneron
2.6.1 Regeneron Details
2.6.2 Regeneron Major Business
2.6.3 Regeneron PD-1 and PD-L1 Inhibitors Product and Services
2.6.4 Regeneron PD-1 and PD-L1 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Regeneron Recent Developments/Updates
2.7 Innovent
2.7.1 Innovent Details
2.7.2 Innovent Major Business
2.7.3 Innovent PD-1 and PD-L1 Inhibitors Product and Services
2.7.4 Innovent PD-1 and PD-L1 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Innovent Recent Developments/Updates
2.8 Hengrui Medicine
2.8.1 Hengrui Medicine Details
2.8.2 Hengrui Medicine Major Business
2.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Product and Services
2.8.4 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hengrui Medicine Recent Developments/Updates
2.9 Junshi Biosciences
2.9.1 Junshi Biosciences Details
2.9.2 Junshi Biosciences Major Business
2.9.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Product and Services
2.9.4 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Junshi Biosciences Recent Developments/Updates
2.10 Merck KGaA
2.10.1 Merck KGaA Details
2.10.2 Merck KGaA Major Business
2.10.3 Merck KGaA PD-1 and PD-L1 Inhibitors Product and Services
2.10.4 Merck KGaA PD-1 and PD-L1 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merck KGaA Recent Developments/Updates
3 Competitive Environment: PD-1 and PD-L1 Inhibitors by Manufacturer
3.1 Global PD-1 and PD-L1 Inhibitors Sales Quantity by Manufacturer (2018-2023)
3.2 Global PD-1 and PD-L1 Inhibitors Revenue by Manufacturer (2018-2023)
3.3 Global PD-1 and PD-L1 Inhibitors Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of PD-1 and PD-L1 Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 PD-1 and PD-L1 Inhibitors Manufacturer Market Share in 2022
3.4.2 Top 6 PD-1 and PD-L1 Inhibitors Manufacturer Market Share in 2022
3.5 PD-1 and PD-L1 Inhibitors Market: Overall Company Footprint Analysis
3.5.1 PD-1 and PD-L1 Inhibitors Market: Region Footprint
3.5.2 PD-1 and PD-L1 Inhibitors Market: Company Product Type Footprint
3.5.3 PD-1 and PD-L1 Inhibitors Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global PD-1 and PD-L1 Inhibitors Market Size by Region
4.1.1 Global PD-1 and PD-L1 Inhibitors Sales Quantity by Region (2018-2029)
4.1.2 Global PD-1 and PD-L1 Inhibitors Consumption Value by Region (2018-2029)
4.1.3 Global PD-1 and PD-L1 Inhibitors Average Price by Region (2018-2029)
4.2 North America PD-1 and PD-L1 Inhibitors Consumption Value (2018-2029)
4.3 Europe PD-1 and PD-L1 Inhibitors Consumption Value (2018-2029)
4.4 Asia-Pacific PD-1 and PD-L1 Inhibitors Consumption Value (2018-2029)
4.5 South America PD-1 and PD-L1 Inhibitors Consumption Value (2018-2029)
4.6 Middle East and Africa PD-1 and PD-L1 Inhibitors Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2018-2029)
5.2 Global PD-1 and PD-L1 Inhibitors Consumption Value by Type (2018-2029)
5.3 Global PD-1 and PD-L1 Inhibitors Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2018-2029)
6.2 Global PD-1 and PD-L1 Inhibitors Consumption Value by Application (2018-2029)
6.3 Global PD-1 and PD-L1 Inhibitors Average Price by Application (2018-2029)
7 North America
7.1 North America PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2018-2029)
7.2 North America PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2018-2029)
7.3 North America PD-1 and PD-L1 Inhibitors Market Size by Country
7.3.1 North America PD-1 and PD-L1 Inhibitors Sales Quantity by Country (2018-2029)
7.3.2 North America PD-1 and PD-L1 Inhibitors Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2018-2029)
8.2 Europe PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2018-2029)
8.3 Europe PD-1 and PD-L1 Inhibitors Market Size by Country
8.3.1 Europe PD-1 and PD-L1 Inhibitors Sales Quantity by Country (2018-2029)
8.3.2 Europe PD-1 and PD-L1 Inhibitors Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific PD-1 and PD-L1 Inhibitors Market Size by Region
9.3.1 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific PD-1 and PD-L1 Inhibitors Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2018-2029)
10.2 South America PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2018-2029)
10.3 South America PD-1 and PD-L1 Inhibitors Market Size by Country
10.3.1 South America PD-1 and PD-L1 Inhibitors Sales Quantity by Country (2018-2029)
10.3.2 South America PD-1 and PD-L1 Inhibitors Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa PD-1 and PD-L1 Inhibitors Market Size by Country
11.3.1 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 PD-1 and PD-L1 Inhibitors Market Drivers
12.2 PD-1 and PD-L1 Inhibitors Market Restraints
12.3 PD-1 and PD-L1 Inhibitors Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of PD-1 and PD-L1 Inhibitors and Key Manufacturers
13.2 Manufacturing Costs Percentage of PD-1 and PD-L1 Inhibitors
13.3 PD-1 and PD-L1 Inhibitors Production Process
13.4 PD-1 and PD-L1 Inhibitors Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 PD-1 and PD-L1 Inhibitors Typical Distributors
14.3 PD-1 and PD-L1 Inhibitors Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global PD-1 and PD-L1 Inhibitors Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global PD-1 and PD-L1 Inhibitors Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck PD-1 and PD-L1 Inhibitors Product and Services
Table 6. Merck PD-1 and PD-L1 Inhibitors Sales Quantity (L), Average Price (USD/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 9. Bristol-Myers Squibb Major Business
Table 10. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product and Services
Table 11. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales Quantity (L), Average Price (USD/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bristol-Myers Squibb Recent Developments/Updates
Table 13. Roche Basic Information, Manufacturing Base and Competitors
Table 14. Roche Major Business
Table 15. Roche PD-1 and PD-L1 Inhibitors Product and Services
Table 16. Roche PD-1 and PD-L1 Inhibitors Sales Quantity (L), Average Price (USD/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Roche Recent Developments/Updates
Table 18. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 19. AstraZeneca Major Business
Table 20. AstraZeneca PD-1 and PD-L1 Inhibitors Product and Services
Table 21. AstraZeneca PD-1 and PD-L1 Inhibitors Sales Quantity (L), Average Price (USD/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. AstraZeneca Recent Developments/Updates
Table 23. Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Ono Pharmaceutical Major Business
Table 25. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product and Services
Table 26. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales Quantity (L), Average Price (USD/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Ono Pharmaceutical Recent Developments/Updates
Table 28. Regeneron Basic Information, Manufacturing Base and Competitors
Table 29. Regeneron Major Business
Table 30. Regeneron PD-1 and PD-L1 Inhibitors Product and Services
Table 31. Regeneron PD-1 and PD-L1 Inhibitors Sales Quantity (L), Average Price (USD/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Regeneron Recent Developments/Updates
Table 33. Innovent Basic Information, Manufacturing Base and Competitors
Table 34. Innovent Major Business
Table 35. Innovent PD-1 and PD-L1 Inhibitors Product and Services
Table 36. Innovent PD-1 and PD-L1 Inhibitors Sales Quantity (L), Average Price (USD/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Innovent Recent Developments/Updates
Table 38. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 39. Hengrui Medicine Major Business
Table 40. Hengrui Medicine PD-1 and PD-L1 Inhibitors Product and Services
Table 41. Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales Quantity (L), Average Price (USD/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Hengrui Medicine Recent Developments/Updates
Table 43. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 44. Junshi Biosciences Major Business
Table 45. Junshi Biosciences PD-1 and PD-L1 Inhibitors Product and Services
Table 46. Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales Quantity (L), Average Price (USD/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Junshi Biosciences Recent Developments/Updates
Table 48. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 49. Merck KGaA Major Business
Table 50. Merck KGaA PD-1 and PD-L1 Inhibitors Product and Services
Table 51. Merck KGaA PD-1 and PD-L1 Inhibitors Sales Quantity (L), Average Price (USD/ml), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Merck KGaA Recent Developments/Updates
Table 53. Global PD-1 and PD-L1 Inhibitors Sales Quantity by Manufacturer (2018-2023) & (L)
Table 54. Global PD-1 and PD-L1 Inhibitors Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global PD-1 and PD-L1 Inhibitors Average Price by Manufacturer (2018-2023) & (USD/ml)
Table 56. Market Position of Manufacturers in PD-1 and PD-L1 Inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and PD-1 and PD-L1 Inhibitors Production Site of Key Manufacturer
Table 58. PD-1 and PD-L1 Inhibitors Market: Company Product Type Footprint
Table 59. PD-1 and PD-L1 Inhibitors Market: Company Product Application Footprint
Table 60. PD-1 and PD-L1 Inhibitors New Market Entrants and Barriers to Market Entry
Table 61. PD-1 and PD-L1 Inhibitors Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global PD-1 and PD-L1 Inhibitors Sales Quantity by Region (2018-2023) & (L)
Table 63. Global PD-1 and PD-L1 Inhibitors Sales Quantity by Region (2024-2029) & (L)
Table 64. Global PD-1 and PD-L1 Inhibitors Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global PD-1 and PD-L1 Inhibitors Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global PD-1 and PD-L1 Inhibitors Average Price by Region (2018-2023) & (USD/ml)
Table 67. Global PD-1 and PD-L1 Inhibitors Average Price by Region (2024-2029) & (USD/ml)
Table 68. Global PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2018-2023) & (L)
Table 69. Global PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2024-2029) & (L)
Table 70. Global PD-1 and PD-L1 Inhibitors Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global PD-1 and PD-L1 Inhibitors Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global PD-1 and PD-L1 Inhibitors Average Price by Type (2018-2023) & (USD/ml)
Table 73. Global PD-1 and PD-L1 Inhibitors Average Price by Type (2024-2029) & (USD/ml)
Table 74. Global PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2018-2023) & (L)
Table 75. Global PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2024-2029) & (L)
Table 76. Global PD-1 and PD-L1 Inhibitors Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global PD-1 and PD-L1 Inhibitors Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global PD-1 and PD-L1 Inhibitors Average Price by Application (2018-2023) & (USD/ml)
Table 79. Global PD-1 and PD-L1 Inhibitors Average Price by Application (2024-2029) & (USD/ml)
Table 80. North America PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2018-2023) & (L)
Table 81. North America PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2024-2029) & (L)
Table 82. North America PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2018-2023) & (L)
Table 83. North America PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2024-2029) & (L)
Table 84. North America PD-1 and PD-L1 Inhibitors Sales Quantity by Country (2018-2023) & (L)
Table 85. North America PD-1 and PD-L1 Inhibitors Sales Quantity by Country (2024-2029) & (L)
Table 86. North America PD-1 and PD-L1 Inhibitors Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America PD-1 and PD-L1 Inhibitors Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2018-2023) & (L)
Table 89. Europe PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2024-2029) & (L)
Table 90. Europe PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2018-2023) & (L)
Table 91. Europe PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2024-2029) & (L)
Table 92. Europe PD-1 and PD-L1 Inhibitors Sales Quantity by Country (2018-2023) & (L)
Table 93. Europe PD-1 and PD-L1 Inhibitors Sales Quantity by Country (2024-2029) & (L)
Table 94. Europe PD-1 and PD-L1 Inhibitors Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe PD-1 and PD-L1 Inhibitors Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2018-2023) & (L)
Table 97. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2024-2029) & (L)
Table 98. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2018-2023) & (L)
Table 99. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2024-2029) & (L)
Table 100. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Quantity by Region (2018-2023) & (L)
Table 101. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Quantity by Region (2024-2029) & (L)
Table 102. Asia-Pacific PD-1 and PD-L1 Inhibitors Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific PD-1 and PD-L1 Inhibitors Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2018-2023) & (L)
Table 105. South America PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2024-2029) & (L)
Table 106. South America PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2018-2023) & (L)
Table 107. South America PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2024-2029) & (L)
Table 108. South America PD-1 and PD-L1 Inhibitors Sales Quantity by Country (2018-2023) & (L)
Table 109. South America PD-1 and PD-L1 Inhibitors Sales Quantity by Country (2024-2029) & (L)
Table 110. South America PD-1 and PD-L1 Inhibitors Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America PD-1 and PD-L1 Inhibitors Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2018-2023) & (L)
Table 113. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Quantity by Type (2024-2029) & (L)
Table 114. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2018-2023) & (L)
Table 115. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Quantity by Application (2024-2029) & (L)
Table 116. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Quantity by Region (2018-2023) & (L)
Table 117. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Quantity by Region (2024-2029) & (L)
Table 118. Middle East & Africa PD-1 and PD-L1 Inhibitors Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa PD-1 and PD-L1 Inhibitors Consumption Value by Region (2024-2029) & (USD Million)
Table 120. PD-1 and PD-L1 Inhibitors Raw Material
Table 121. Key Manufacturers of PD-1 and PD-L1 Inhibitors Raw Materials
Table 122. PD-1 and PD-L1 Inhibitors Typical Distributors
Table 123. PD-1 and PD-L1 Inhibitors Typical Customers
List of Figures
Figure 1. PD-1 and PD-L1 Inhibitors Picture
Figure 2. Global PD-1 and PD-L1 Inhibitors Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global PD-1 and PD-L1 Inhibitors Consumption Value Market Share by Type in 2022
Figure 4. PD-1 Inhibitors Examples
Figure 5. PD-L1 Inhibitors Examples
Figure 6. Global PD-1 and PD-L1 Inhibitors Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global PD-1 and PD-L1 Inhibitors Consumption Value Market Share by Application in 2022
Figure 8. Solid Tumors Examples
Figure 9. Blood-related Tumors Examples
Figure 10. Global PD-1 and PD-L1 Inhibitors Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global PD-1 and PD-L1 Inhibitors Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global PD-1 and PD-L1 Inhibitors Sales Quantity (2018-2029) & (L)
Figure 13. Global PD-1 and PD-L1 Inhibitors Average Price (2018-2029) & (USD/ml)
Figure 14. Global PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global PD-1 and PD-L1 Inhibitors Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of PD-1 and PD-L1 Inhibitors by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 PD-1 and PD-L1 Inhibitors Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 PD-1 and PD-L1 Inhibitors Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global PD-1 and PD-L1 Inhibitors Consumption Value Market Share by Region (2018-2029)
Figure 21. North America PD-1 and PD-L1 Inhibitors Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe PD-1 and PD-L1 Inhibitors Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific PD-1 and PD-L1 Inhibitors Consumption Value (2018-2029) & (USD Million)
Figure 24. South America PD-1 and PD-L1 Inhibitors Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa PD-1 and PD-L1 Inhibitors Consumption Value (2018-2029) & (USD Million)
Figure 26. Global PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global PD-1 and PD-L1 Inhibitors Consumption Value Market Share by Type (2018-2029)
Figure 28. Global PD-1 and PD-L1 Inhibitors Average Price by Type (2018-2029) & (USD/ml)
Figure 29. Global PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global PD-1 and PD-L1 Inhibitors Consumption Value Market Share by Application (2018-2029)
Figure 31. Global PD-1 and PD-L1 Inhibitors Average Price by Application (2018-2029) & (USD/ml)
Figure 32. North America PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America PD-1 and PD-L1 Inhibitors Consumption Value Market Share by Country (2018-2029)
Figure 36. United States PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe PD-1 and PD-L1 Inhibitors Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific PD-1 and PD-L1 Inhibitors Consumption Value Market Share by Region (2018-2029)
Figure 52. China PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America PD-1 and PD-L1 Inhibitors Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa PD-1 and PD-L1 Inhibitors Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa PD-1 and PD-L1 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. PD-1 and PD-L1 Inhibitors Market Drivers
Figure 73. PD-1 and PD-L1 Inhibitors Market Restraints
Figure 74. PD-1 and PD-L1 Inhibitors Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Inhibitors in 2022
Figure 77. Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
Figure 78. PD-1 and PD-L1 Inhibitors Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
